https://invesbrain.com/blueprint-medicines-gets-more-ducks-in-a-row-before-ceo-transition-paul-stoffels-has-his-work-cut-out-for-him-at-gileads-crumbling-partner/
Blueprint Medicines gets more ducks in a row before CEO transition; Paul Stoffels has his work cut out for him at Gilead’s crumbling partner